Pharmafile Logo
Pharmafocus logo
Advanced Search

Dr Paolo Paoletti

Showing 1 posts of 1 posts found.

dr_paolo_paoletti

PsiOxus Therapeutics appoints Dr Paolo Paoletti as chairman of the board

January 7, 2016
Manufacturing and Production, Medical Communications, Research and Development Cancer, Dr Paolo Paoletti, GSK, PsiOxus Therapeutics, immuno-oncology, oncology

Immuno-oncology company PsiOxus Therapeutics has appointed Kesios Therapeutics chief executive, and former president of GSK Oncology, Dr Paolo Paoletti, as chairman …

Appointment
The Gateway to Local Adoption Series

Latest content

Survey highlights mental health burden among rare disease patients and families

November 5, 2026

Addressing the rheumatic disease diagnostic gap in primary care

November 5, 2026

How chronic disease creates opportunity on diagnostic and therapeutic pipelines

November 4, 2026

EnteroBiotix appoints former GSK Chief Medical Officer to board

November 3, 2026

Stryker invests US$400m in CMR Surgical and secures option to acquire business

November 3, 2026